Movatterモバイル変換


[0]ホーム

URL:


GB9107368D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9107368D0
GB9107368D0GB919107368AGB9107368AGB9107368D0GB 9107368 D0GB9107368 D0GB 9107368D0GB 919107368 AGB919107368 AGB 919107368AGB 9107368 AGB9107368 AGB 9107368AGB 9107368 D0GB9107368 D0GB 9107368D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919107368A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham LtdfiledCriticalSmithKline Beecham Ltd
Priority to GB919107368ApriorityCriticalpatent/GB9107368D0/en
Publication of GB9107368D0publicationCriticalpatent/GB9107368D0/en
Priority to EP92907701Aprioritypatent/EP0579650A1/en
Priority to JP4507178Aprioritypatent/JPH06505989A/en
Priority to PCT/GB1992/000611prioritypatent/WO1992017460A1/en
Pendinglegal-statusCriticalCurrent

Links

Classifications

Landscapes

GB919107368A1991-04-081991-04-08Novel compoundsPendingGB9107368D0 (en)

Priority Applications (4)

Application NumberPriority DateFiling DateTitle
GB919107368AGB9107368D0 (en)1991-04-081991-04-08Novel compounds
EP92907701AEP0579650A1 (en)1991-04-081992-04-06Novel compounds
JP4507178AJPH06505989A (en)1991-04-081992-04-06 Azalactam hydroxamic acid derivatives as collagenase inhibitors
PCT/GB1992/000611WO1992017460A1 (en)1991-04-081992-04-06Novel compounds

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GB919107368AGB9107368D0 (en)1991-04-081991-04-08Novel compounds

Publications (1)

Publication NumberPublication Date
GB9107368D0true GB9107368D0 (en)1991-05-22

Family

ID=10692843

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB919107368APendingGB9107368D0 (en)1991-04-081991-04-08Novel compounds

Country Status (4)

CountryLink
EP (1)EP0579650A1 (en)
JP (1)JPH06505989A (en)
GB (1)GB9107368D0 (en)
WO (1)WO1992017460A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO1994021612A1 (en)*1993-03-181994-09-29Otsuka Pharmaceutical Co., Ltd.Carbostyril derivatives as matrix metalloproteinases inhibitors
US5594006A (en)*1993-03-181997-01-14Otsuka Pharmaceutical Co., Ltd.Carbostyril derivatives as matrix metalloproteinases inhibitors
EP0740652B1 (en)*1994-01-201998-05-06British Biotech Pharmaceuticals LimitedMetalloproteinase inhibitors
GB9423914D0 (en)*1994-11-261995-01-11British Biotech PharmPolyether derivatives as metalloproteinase inhibitors
US5639746A (en)*1994-12-291997-06-17The Procter & Gamble CompanyHydroxamic acid-containing inhibitors of matrix metalloproteases
US5919940A (en)*1995-01-201999-07-06British Biotech Pharmaceuticals LimitedMetalloproteinase inhibitors
US5672598A (en)*1995-03-211997-09-30The Procter & Gamble CompanyLactam-containing hydroxamic acids
US5917090A (en)*1995-06-301999-06-29British Biotech Pharmaceuticals Ltd.Matrix metalloproteinase inhibitors
US6127427A (en)1995-11-232000-10-03British Biotech Pharmaceuticals LimitedMetalloproteinase inhibitors
ATE272062T1 (en)*1996-08-282004-08-15Procter & Gamble SPIROCYCLIC METALLOPROTEASE INHIBITORS
EP0927168B1 (en)*1996-08-282002-11-06The Procter & Gamble Company1,3-diheterocyclic metalloprotease inhibitors
CA2263917A1 (en)*1996-08-281998-03-05Kelly Lynn Mcdow-DunhamHeterocyclic metalloprotease inhibitors
CZ63699A3 (en)*1996-08-281999-07-14The Procter & Gamble CompanyCompounds based on amides of phosphinic acid as inhibitors of intercellular matter metalloproteases, process of their preparation and their use as medicaments
HUP0000505A3 (en)*1996-08-282001-12-28Procter & GambleSaturated 7-9 membered heterocyclic n-hydroxycarboxamide derivatives and pharmaceutical compositions containing them
US6462023B1 (en)1996-09-102002-10-08British Biotech Pharmaceuticals, Ltd.Cytostatic agents
ATE220660T1 (en)1996-09-102002-08-15British Biotech Pharm CYTOSTATIC HYDROXAMIC ACID DERIVATIVES
IL134273A0 (en)1997-07-312001-04-30Procter & GambleAcyclic metalloprotease inhibitors
US6329418B1 (en)1998-04-142001-12-11The Procter & Gamble CompanySubstituted pyrrolidine hydroxamate metalloprotease inhibitors
NZ525513A (en)1998-08-072004-09-24Pont Pharmaceuticals DuSuccinoylamino lactams as inhibitors of Abeta protein production
HRP990246A2 (en)1998-08-072000-06-30Du Pont Pharm CoSuccinoylamino benzodiazepines as inhibitors of a beta protein production
AU778005B2 (en)1998-12-242004-11-11Bristol-Myers Squibb Pharma CompanySuccinoylamino benzodiazepines as inhibitors of Abeta protein production
US6566381B1 (en)1999-03-032003-05-20The Procter & Gamble CompanyHetero-substituted metalloprotease inhibitors
RU2001126721A (en)1999-03-032004-02-20Дзе Проктер Энд Гэмбл Компани (US) Alkenyl and alkynyl-containing metal prosthetics inhibitors
US6696456B1 (en)1999-10-142004-02-24The Procter & Gamble CompanyBeta disubstituted metalloprotease inhibitors
WO2001060826A2 (en)2000-02-172001-08-23Bristol-Myers Squibb Pharma CompanySUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
EP1265865A2 (en)2000-03-212002-12-18The Procter & Gamble CompanyDifluorobutyric acid derivatives and their use as metalloprotease inhibitors
IL151125A0 (en)2000-03-212003-04-10Procter & GambleHeterocyclic side chain containing, n-substituted metalloprotease inhibitors
US6495540B2 (en)2000-03-282002-12-17Bristol - Myers Squibb Pharma CompanyLactams as inhibitors of A-β protein production
EP1268434A1 (en)2000-04-032003-01-02Bristol-Myers Squibb Pharma CompanyCyclic lactams as inhibitors of a-beta protein production
JP2003535046A (en)2000-04-032003-11-25デュポン ファーマシューティカルズ カンパニー Cyclic lactams as inhibitors of Aβ protein production
IL147629A0 (en)2000-06-012002-08-14Bristol Myers Squibb Pharma CoLACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP0054862B1 (en)*1980-12-181985-11-27Schering CorporationSubstituted dipeptides, processes for their preparation and pharmaceutical compositions containing them and their use in the inhibition of enkephalinase
EP0401963A1 (en)*1989-04-131990-12-12Beecham Group p.l.c.Phosphonopeptides with collagenase inhibiting activity
GB9000846D0 (en)*1990-01-151990-03-14Beecham Group PlcNovel compounds

Also Published As

Publication numberPublication date
EP0579650A1 (en)1994-01-26
JPH06505989A (en)1994-07-07
WO1992017460A1 (en)1992-10-15

Similar Documents

PublicationPublication DateTitle
GB9107368D0 (en)Novel compounds
GB9104839D0 (en)Novel compounds
GB9116207D0 (en)Novel compounds
GB9106491D0 (en)Novel compounds
GB9105606D0 (en)Novel compounds
GB9121035D0 (en)Novel compounds
GB9121041D0 (en)Novel compounds
GB9123008D0 (en)Novel compounds
GB9123625D0 (en)Novel compounds
GB9127201D0 (en)Novel compounds
AP9100267A0 (en)Novel compounds
GB9114106D0 (en)Novel compounds
GB9105583D0 (en)Novel compounds
GB9105584D0 (en)Novel compounds
GB9105585D0 (en)Novel compounds
GB9107369D0 (en)Novel compounds
GB9105683D0 (en)Novel compounds
GB9106079D0 (en)Novel compounds
GB9106080D0 (en)Novel compounds
GB9106092D0 (en)Novel compounds
GB9106093D0 (en)Novel compounds
GB9106094D0 (en)Novel compounds
GB9106490D0 (en)Novel compounds
GB9109540D0 (en)Novel compounds
GB9107367D0 (en)Novel compounds

[8]ページ先頭

©2009-2025 Movatter.jp